PURDUE PHARMA (CANADA) APPOINTS ANDRÉ CÔTÉ VICE PRESIDENT, HEALTH SOLUTIONS

May 22, 2018

Andre CotePICKERING, ON, May 22, 2018 /CNW/ — André Côté is appointed Vice President, Health Solutions at Purdue Pharma (Canada), bringing 25 years of broad customer-centric pharmaceutical experience. He will be accountable for developing commercial capability and driving sales performance in line with Health Canada approved product monographs across our diverse portfolio.

“André’s drive to create solutions-oriented interactions with customers, his passion for supporting employee growth and development, his broad experience and high ethical standards will sharpen our ability to help healthcare professionals support their patients through research-driven and balanced interactions about clinical practice guidelines and our diversified product portfolio,” says David Pidduck, President and CEO.

Throughout his career he has held roles with increasing scope and accountability across the commercial operations of an innovative pharmaceutical organization, both nationally and globally, that has included sales, learning and development, business development, market access, pricing, commercial capabilities, launch excellence and customer experience.

“I’m excited to join a team committed to delivering research-based solutions to healthcare professionals as they work to meet their patients’ needs – whether it is in a hospital, trauma care, primary care or palliative care setting”, says Côté . “Purdue’s legacy of discovery, innovation, community support, and employee growth and wellness drive my excitement for our collective future success.”

André holds a Bachelor of Business Administration (Marketing) from Laval University and acts as an industry speaker in pharmaceutical healthcare forums and serves as a North American Panel Judge for the Eye-For-Pharma Awards.

About Purdue Pharma (Canada)
Purdue Pharma (Canada) is a research-based pharmaceutical and consumer healthcare company which has operated in Canada for over 60 years. Its 400 employees are committed to improving the health and quality of life of Canadians. The company has a broad portfolio of prescription and non-prescription medications including: prescription treatments for pain, ADHD, chemotherapy-induced nausea and vomiting (CINV), various ophthalmic conditions and Consumer Healthcare products. The company supports evidence-based education for the safe use of its products. Its headquarters, located in Pickering, ON, includes integrated research & development, formulation and manufacturing operations. Privately held and founded by physicians, Purdue Pharma (Canada) is independently associated with the worldwide Purdue/Napp/Mundipharma network of companies. Learn more at www.purdue.ca

Media Inquiries:
Paya Farahmand
media@purdue.ca